Ovarian cancer is the fourth leading cause of death in American women and according to the National Cancer Institute, approximately 22,000 women will be diagnosed with the disease and 14,000 will die from it.
Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death, according to researchers from the Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center at Yale School of Medicine and Yale Cancer Center.
The NIH has awarded Einstein researchers three grants totaling more than $12 million to protect against three deadly viruses—Ebola, Marburg and hantavirus. Research collaborations between Kartik Chandran, Ph.D., professor of microbiology & immunology and the Harold and Muriel Block Faculty Scholar in Virology, and Jonathan Lai, Ph.D., associate professor of biochemistry, have led to novel approaches for developing vaccines and treatments.
ACTRIMS' third annual forum will be Feb. 1-3 in San Diego, California and will focus on therapeutic targets in multiple sclerosis with emphasis on disease-modifying therapies. New at the 2018 forum is the presentation by the National Multiple Sclerosis Society of the Barancik Prize for Innovation in Multiple Sclerosis Research, recognizing work in MS research that demonstrates outstanding innovation and originality.
The GI Quality Improvement Consortium, Inc. (GIQuIC) is in the process of moving to a new, more agile technical platform that will better support participants and their teams in their utilization of the GIQuIC registry for clinical benchmarking, quality improvement, and reporting to payers.
The International Union of Physiological Sciences (IUPS) released the new report “Physiology: Current Trends and Future Challenges” to delegates attending its World Congress, which was held August 1–5, 2017, in Rio de Janeiro. The landmark report outlines seven recommendations to help physiologists and professional scientific societies grow and support physiology.
B-Line Medical, Children’s Hospital of Philadelphia host 3rd “Lifesaver” Benefit Concert in our Nation's Capital
The opioid crisis in the United States is resulting in increased admissions to hospital intensive care units and in increased numbers of ICU deaths from opioid overdoses, according to new research published online, ahead of print in the Annals of the American Thoracic Society.
Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20. The disease, called Niemann-Pick type C (NPC), causes cholesterol to build up in neurons, leading to a gradual loss of brain function. In the drug trial, researchers have shown that treatment with a type of sugar molecule called cyclodextrin slows progression of the disease.
Patients with different chronic pain diagnoses recorded similar brain changes, a new study finds, suggesting a need for new treatment approaches.
Heavy drinking can have a number of negative consequences, including sex that is later regretted. Low sensitivity (LS) to alcohol’s effects – which characterizes the person who can “drink everyone under the table” – is a known risk factor for heavy drinking and its consequences. This study investigated LS and regretted sex from an unusual perspective, asking whether LS could be protective in some contexts, given that LS drinkers are generally less impaired from drinking at a given level. More specifically, the investigators tested whether LS was associated with differences in reports by men and women of alcohol-related regretted sex.
• Investigators observed a step-wise increase in the risk of atrial fibrillation with decreasing kidney function. Compared with patients without kidney disease, those with severe kidney disease had a two-fold higher risk for developing atrial fibrillation. • This link held even after accounting for a range of possible contributors, including measures of cardiovascular health, and it was consistent across subgroups of participants.
An international team of scientists, led by University of California San Diego School of Medicine researchers, has created a human stem cell-based model of a rare, but devastating, inherited neurological autoimmune condition called Aicardi-Goutieres Syndrome (AGS). In doing so, the team was able to identify unusual and surprising underlying genetic mechanisms that drive AGS and test strategies to inhibit the condition using existing drugs.
A little-studied gene may explain how some liver cancer cells obtain the nutrition they need to proliferate, according to new research from the University of Maryland.
School-based mental health programs can reach large numbers of children, with increasing evidence of effectiveness in improving mental health and related outcomes, according to a research review in the September/October issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Fred Hutchinson Cancer Research Center is launching a new integrated research center to prevent and find cures for cancers caused by infectious agents. It will be led by Dr. Denise Galloway, a Fred Hutch microbiologist whose research paved the way for the HPV vaccine, which prevents cervical, throat and other cancers.
Currently, testing for Zika requires that a blood sample be refrigerated and shipped to a medical center or laboratory, delaying diagnosis and possible treatment. Now, Washington University in St. Louis researchers have developed a test that quickly can detect the presence of Zika virus in blood. Although the new proof-of-concept technology has yet to be produced for use in medical situations, test results can be determined in minutes, and the materials do not require refrigeration.
Athletes at all levels are pressured to be physically superior, which can cause many to overlook their mental health needs.
Undergraduate summer research fellowships let students pursue their passions. Daniel Craven used a BioBots three-dimensional bioprinter to make small polymer scaffolds that can hold cells for tissue engineering. The scaffolds, less than half an inch thick, are biocompatible and biodegradable.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right